Targeting CXCR3 reduces ligand-induced T-Cell activation but not development of lung allergic responses

CXCR3 antagonism did not prevent allergen-induced airway hyperresponsiveness or airway inflammation in a mouse allergy model despite having activity in in vitro functional assays.